We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTR
1351
DELISTED
Altair Engineering Inc
ALTR
$228K 0.02%
+2,086
New +$215K
EXAS
1352
DELISTED
Exact Sciences
EXAS
$227K 0.02%
+4,034
New +$251K
HL icon
1353
Hecla Mining
HL
$11.3B
$227K 0.02%
46,135
-71,876
-61% -$430K
LAB icon
1354
Standard BioTools
LAB
$314M
$227K 0.02%
+129,734
New +$242K
MD icon
1355
Pediatrix Medical
MD
$2.2B
$227K 0.02%
17,279
-4,226
-20% -$58.3K
SMLR
1356
DELISTED
Semler Scientific
SMLR
$227K 0.02%
4,195
-6,141
-59% -$282K
IRMD icon
1357
iRadimed
IRMD
$1.18B
$226K 0.02%
4,106
-4,412
-52% -$232K
XSW icon
1358
State Street SPDR S&P Software & Services ETF
XSW
$484M
$226K 0.02%
+1,194
New +$217K
YETI icon
1359
Yeti Holdings
YETI
$3.95B
$225K 0.02%
+5,846
New +$232K
RTH icon
1360
VanEck Retail ETF
RTH
$263M
$224K 0.02%
999
-249
-20% -$56K
SLVM icon
1361
Sylvamo
SLVM
$1.63B
$223K 0.02%
2,817
-3,072
-52% -$265K
STR
1362
DELISTED
Sitio Royalties
STR
$223K 0.02%
+11,620
New +$259K
CANG
1363
Cango Inc
CANG
$68.5M
$222K 0.02%
+5,053
New +$174K
DRVN icon
1364
Driven Brands
DRVN
$2.2B
$222K 0.02%
13,768
-35,090
-72% -$550K
ELF icon
1365
e.l.f. Beauty
ELF
$5.81B
$222K 0.02%
1,772
-11,273
-86% -$1.35M
UTMD icon
1366
Utah Medical Products
UTMD
$225M
$222K 0.02%
3,607
+152
+4% +$9.83K
VKTX icon
1367
Viking Therapeutics
VKTX
$4B
$222K 0.02%
5,522
-2,638
-32% -$150K
GEHC icon
1368
GE HealthCare
GEHC
$32.4B
$221K 0.02%
2,825
-6,488
-70% -$551K
ARWR icon
1369
Arrowhead Research
ARWR
$12.4B
$219K 0.02%
+11,667
New +$240K
KVUE icon
1370
Kenvue
KVUE
$36.9B
$219K 0.02%
+10,241
New +$232K
NBN icon
1371
Northeast Bank
NBN
$1.14B
$219K 0.02%
+2,391
New +$220K
ADAM
1372
Adamas Trust
ADAM
$883M
$217K 0.02%
+35,789
New +$210K
SVV icon
1373
Savers
SVV
$1.88B
$217K 0.02%
21,135
-2,443
-10% -$24.3K
VRDN icon
1374
Viridian Therapeutics
VRDN
$2.67B
$217K 0.02%
+11,332
New +$246K
CMRC
1375
Commerce.com Inc Series 1
CMRC
$184M
$216K 0.02%
+35,355
New +$221K
53 54
55
56 57

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.